Martin et al: Advances in cationic lipid-mediated gene deliveryBoucher RC (1999) Status of gene therapy for cystic fibrosislung disease. J Clin Invest 103, 441-445Boulikas T (1997) Nuclear localization signal peptides for theimport of plasmid DNA in gene therapy (Review). Int JOncol 10, 301-309Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D,Demeneix B, Behr JP (1995) A Versatile Vector for <strong>Gene</strong>and Oligonucleotide Transfer into Cells in Culture and in-Vivo - Polyethylenimine. Proc Natl Acad Sci U S A 92,7297-7301Brunette E, Stribling R, Debs R (1992) Lipofection does notrequire the removal of serum. Nucleic Acids Res 20, 1151Byk G, Dubertret C, Escriou V, Frederic M, Jaslin G, Rangara R,Pitard B, Crouzet J, Wils P, Schwartz B, Scherman D (1998)Synthesis, Activity, and Structure-Activity RelationshipStudies of Novel Cationic Lipids for DNA Transfer. J MedChem 41, 224-235Capecchi MR (1980) High efficiency transformation by directmicroinjection of DNA into cultured mammalian cells. Cell22, 479-488Ciolina C, Byk G, Blanche F, Thuillier V, Scherman D, Wils P(1999) Coupling of Nuclear Localization Signals to PlasmidDNA and Specific Interaction of the Conjugates withImportin a. Bioconjug Chem 10, 49-55Collas P, Husebye H, Alestrom P (1996) The nuclear localizationsequence of the SV40 T antigen promotes transgene uptakeand expression in zebrafish embryo nuclei. Transgenic Res5, 451-458Crystal RG (1995) Transfer of genes to humans: early lessonsand obstacles to success. Science 270, 404-410Davies JC, Geddes DM, Alton EW (2001) <strong>Gene</strong> therapy forcystic fibrosis. J <strong>Gene</strong> Med 3, 409-417Demeneix BA, Behr J-P. The Proton Sponge: A Trick theViruses Did Not Exploit. In: Felgner PL, Heller, H.J., Lehn,P., Behr, J.-P., Szoka, Jr.F.C. Eds (ed). Artificial Self-Assembling Systems for <strong>Gene</strong> Delivery. American ChemicalSociety, Washington, DC, USA, 1996, pp. 146-151.Ellens H, Bentz J, Szoka FC (1986) Fusion ofphosphatidylethanolamine-containing liposomes andmechanism of La-HII phase transition. Biochemistry 25,4141-4147Escriou V, Carriere M, Bussone F, Wils P, Scherman D (2001)Critical assessment of the nuclear import of plasmid duringcationic lipid-mediated gene transfer. J <strong>Gene</strong> Med 3, 179-187Escriou V, Carriere M, Scherman D, Wils P (2003) NLSbioconjugates for targeting therapeutic genes to the nucleus.Adv Drug Deliv Rev 55, 295-306Escriou V, Ciolina C, Helbling-Leclerc A, Wils P, Scherman D(1998) Cationic lipid-mediated gene transfer: analysis ofcellular uptake and nuclear import of plasmid DNA. CellBiol Toxicol 14, 95-104Ewert K, Ahmad A, Evans HM, Schmidt H-W, Safinya CR(2002) Efficient synthesis and cell-transfection properties ofa new multivalent cationic lipid for nonviral gene delivery. JMed Chem 45, 5023-5029Fajac I, Briand P, Monsigny M, Midoux P (1999) Sugarmediateduptake of glycosylated polylysines and genetransfer into normal and cystic fibrosis airway epithelialcells. Hum <strong>Gene</strong> Ther 10, 395-406Farhood H, Serbina N, Huang L (1995) The Role of DioleoylPhosphatidylethanolamine in Cationic Liposome-Mediated<strong>Gene</strong>-Transfer. Biochim Biophys Acta 1235, 289-295Fasbender A, Zabner J, Zeiher BG, Welsh MJ (1997) A low rateof cell proliferation and reduced DNA uptake limit cationiclipid-mediated gene transfer to primary cultures of ciliatedhuman airway epithelia. <strong>Gene</strong> Ther 4, 1173-1180Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, BorderR, Ramsey P, Martin M, Felgner PL (1994) Enhanced genedelivery and mechanism studies with a novel series ofcationic lipid formulations. J Biol Chem 269, 2550-2561Felgner PL. Progress in gene delivery research and development.In: Huang L, Hung, M.C., Wagner, E., Eds (ed). NonviralVectors for <strong>Gene</strong> <strong>Therapy</strong>. Academic Press, San Diego,USA, 1999, pp. 25-38.Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M,Northrop JP, Ringold GM, Danielsen M (1987) Lipofection:a highly efficient, lipid-mediated DNA-transfectionprocedure. Proc Natl Acad Sci U S A 84, 7413-7417Felgner PL, Ringold GM (1989) Cationic liposome-mediatedtransfection. Nature 337, 387-388Fichert T, Regelin A, Massing U (2000) Synthesis andtransfection properties of novel non-toxic monocationiclipids. Variation of lipid anchor, spacer and head groupstructure. Bioorg Med Chem Lett 10, 787-791Floch V, Legros N, Loisel S, Guillaume C, Guilbot J, BenvegnuT, Ferrieres V, Plusquellec D, Ferec C (1998) Newbiocompatible cationic amphiphiles derivative from glycinebetaine: a novel family of efficient nonviral gene transferagents. Biochem Biophys Res Commun 251, 360-365Friend DS, Papahadjopoulos D, Debs RJ (1996) Endocytosis andintracellular processing accompanying transfection mediatedby cationic liposomes. Biochim Biophys Acta 1278, 41-50Fujiwara T, Hasegawa S, Hirashima N, Nakanishi M, Ohwada T(2000) <strong>Gene</strong> transfection activities of amphiphilic steroidpolyamineconjugates. Biochim Biophys Acta 1468, 396-402Gao X, Huang L (1991) A novel cationic liposome reagent forefficient transfection of mammalian cells. Biochem BiophysRes Commun 179, 280-285Gao X, Huang L (1993) Cationic liposomes and polymers forgene transfer. J Lip Res 3, 17-30Gao X, Huang L (1995) Cationic liposome-mediated genetransfer. <strong>Gene</strong> Ther 2, 710-722Geall AJ, Eaton MAW, Baker T, Catterall C, Blagbrough IS(1999) The regiochemical distribution of positive chargesalong cholesterol polyamine carbamates plays significantroles in modulating DNA binding affinity and lipofection.FEBS Lett 459, 337-342Gershon H, Ghirlando R, Guttman SB, Minsky A (1993) Modeof formation and structural features of DNA-cationicliposome complexes used for transfection. Biochemistry 32,7143-7151Ghosh YK, Visweswariah SS, Bhattacharya S (2000) Nature oflinkage between the cationic headgroup and cholesterylskeleton controls gene transfection efficiency. FEBS Lett473, 341-344Goff SP (2001) Intracellular trafficking of retroviral genomesduring the early phase of infection: viral exploitation ofcellular pathways. J <strong>Gene</strong> Med 3, 517-528Gottschalk S, Sparrow JT, Hauer J, Mims MP, Leland FE, WooSLC, Smith LC (1996) A novel DNA-peptide complex forefficient gene transfer and expression in mammalian cells.<strong>Gene</strong> Ther 3, 448-457Griesenbach U, Geddes DM, Alton EWFW. Cystic fibrosis genetherapy. In: Huang L, Hung, M.C., Wagner, E., Eds (ed).Nonviral Vectors for <strong>Gene</strong> <strong>Therapy</strong>. Academic Press, SanDiego, USA, 1999, pp. 337-356.Guenin E, Herve A-C, Floch V, Loisel S, Yaouanc J-J, ClementJ-C, Ferec C, Des Abbayes H (2000) Cationicphosphonolipids containing quaternary phosphonium andarsonium groups for DNA transfection with good efficiencyand low cellular toxicity. Angew Chem Int Ed 39, 629-631286
<strong>Gene</strong> <strong>Therapy</strong> and <strong>Molecular</strong> <strong>Biology</strong> Vol 7, page 287Guo X, Szoka FC, Jr. (2003) Chemical Approaches toTriggerable Lipid Vesicles for Drug and <strong>Gene</strong> Delivery. AccChem Res 36, 335-341Gustafsson J, Arvidson G, Karlsson G, Almgren M (1995)Complexes between cationic liposomes and DNA visualizedby cryo-TEM. Biochim Biophys Acta 1235, 305-312Harvie P, Wong FMP, Bally MB (2000) Use of poly(ethyleneglycol)-lipid conjugates to regulate the surface attributes andtransfection activity of lipid-DNA particles. J Pharm Sci 89,652-663Hasegawa S, Hirashima N, Nakanishi M (2001) Microtubuleinvolvement in the intracellular dynamics for genetransfection mediated by cationic liposomes. <strong>Gene</strong> Ther 8,1669-1673Hasegawa S, Hirashima N, Nakanishi M (2002) Comparativestudy of transfection efficiency of cationic cholesterolsmediated by liposomes-based gene delivery. Bioorg MedChem Lett 12, 1299-1302Hendrix M, Alper PB, Priestley ES, Wong C-H (1997)Hydroxyamines as a new motif for the molecular recognitionof phosphodiesters: implications for aminoglycoside-RNAinteractions. Angew Chem Int Ed 36, 95-98Hersh EM, Stopeck AT. Cancer gene therapy using nonviralvectors: preclinical and clinical observations. In: KabanovAV, Felgner P.L., Seymour, L.W. Eds (ed). Self-assemblingComplexes for <strong>Gene</strong> Delivery. John Wiley and Sons,Chichester, UK, 1998, pp. 421-436.Heyes JA, Niculescu-Duvaz D, Cooper RG, Springer CJ (2002)Synthesis of Novel Cationic Lipids: Effect of StructuralModification on the Efficiency of <strong>Gene</strong> Transfer. J MedChem 45, 99-114Hong K, Zheng W, Baker A, Papahadjopoulos D (1997)Stabilization of cationic liposome-plasmid DNA complexesby polyamines and poly(ethylene glycol)-phospholipidconjugates for efficient in vivo gene delivery. FEBS Lett400, 233-237Ihm J-E, Han K-O, Han I-K, Ahn K-D, Han D-K, Cho C-S(2003) High Transfection Efficiency of Poly(4-vinylimidazole) as a New <strong>Gene</strong> Carrier. Bioconjug Chem14, 707-708Kaneko T, Willner D, Monkovic I, Knipe JO, Braslawsky GR,Greenfield RS, Vyas DM (1991) New hydrazone derivativesof Adriamycin and their immunoconjugates - a correlationbetween acid stability and cytotoxicity. Bioconjug Chem 2,133-141Keller M, Harbottle RP, Perouzel E, Colin M, Shah I, Rahim A,Vaysse L, Bergau A, Moritz S, Brahimi-Horn C, Coutelle C,Miller AD (2003) Nuclear localisation sequence templatednonviral gene delivery vectors: Investigation of intracellulartrafficking events of LMD and LD vector systems.Chembiochem 4, 286-298Kirpotin D, Hong K, Mullah N, Papahadjopoulos D, Zalipsky S(1996) Liposomes with detachable polymer coating:destabilization and fusion ofdioleoylphosphatidylethanolamine vesicles triggered bycleavage of surface-grafted poly(ethylene glycol). FEBSLett 388, 115-118Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990)Amphipathic polyethylene glycols effectively prolong thecirculation time of liposomes. FEBS Lett 268, 235-237Koltover I, Salditt T, Radler JO, Safinya CR (1998) An invertedhexagonal phase of cationic liposome-DNA complexesrelated to DNA release and delivery. Science 281, 78-81Kootstra NA, Verma IM (2003) <strong>Gene</strong> therapy with viral vectors.Annu Rev Pharmacol Toxicol 43, 413-439Kratz F, Beyer U, Schumacher P, Kruger M, Zahn H, Roth T,Fiebig HH, Unger C (1997) Synthesis of new maleimidederivatives of daunorubicin and biological activity of acidlabile transferrin conjugates. Bioorg Med Chem Lett 7, 617-622Kumar VV, Pichon C, Refregiers M, Guerin B, Midoux P,Chaudhuri A (2003) Single histidine residue in head-groupregion is sufficient to impart remarkable gene transfectionproperties to cationic lipids: evidence for histidine-mediatedmembrane fusion at acidic pH. <strong>Gene</strong> Ther 10, 1206-1215Labat-Moleur F, Steffan AM, Brisson C, Perron H, Feugeas O,Furstenberger P, Oberling F, Brambilla E, Behr JP (1996) Anelectron microscopy study into the mechanism of genetransfer with lipopolyamines. <strong>Gene</strong> Ther 3, 1010-1017Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D(1991) Sterically stabilized liposomes: a hypothesis on themolecular origin of the extended circulation times. BiochimBiophys Acta 1070, 187-192Lasic DD, Papahadjopoulos D, Podgornik R. Polymorphism oflipids, nucleic acids and their interactions. In: Kabanov AV,Felgner P.L., Seymour, L.W. Eds (ed). Self-assemblingComplexes for <strong>Gene</strong> Delivery. John Wiley and Sons,Chichester, UK, 1998, pp. 3-26.Lasic DD, Strey H, Stuart MCA, Podgornik R, Frederik PM(1997) The Structure of DNA-Liposome Complexes. J AmChem Soc 119, 832-833Laxmi AA, Vijayalakshmi P, Balagopala Kaimal TN, ChaudhuriA, Ramadas Y, Rao NM (2001) Novel Non-Glycerol-BasedCytofectins with Lactic Acid-Derived Head Groups.Biochem Biophys Res Commun 289, 1057-1062Lechardeur D, Sohn KJ, Haardt M, Joshi PB, Monck M, GrahamRW, Beatty B, Squire J, O'Brodovich H, Lukacs GL (1999)Metabolic instability of plasmid DNA in the cytosol: apotential barrier to gene transfer. <strong>Gene</strong> Ther 6, 482-497Lee RJ, Huang L (1997) Lipidic vector systems for gene transfer.Crit Rev Ther Drug Carrier Syst 14, 173-206Lehn J-M (1993) Supramolecular chemistry - molecularinformation and the design of supramolecular materials.Makromol Chem, Macromol Symp 69, 1-17Lehn J-M. Preface. In: Huang L, Hung, M.C., Wagner, E., Eds(ed). Nonviral Vectors for <strong>Gene</strong> <strong>Therapy</strong>. Academic Press,San Diego, USA, 1999, pp. xxi.Lehn P, Fabrega S, Oudrhiri N, Navarro J (1998) <strong>Gene</strong> deliverysystems: Bridging the gap between recombinant viruses andartificial vectors. Adv Drug Deliv Rev 30, 5-11Li S, Huang L (1996) Lipidic supramolecular assemblies forgene transfer. J Lip Res 6, 589-608Li S, Huang L (2000) Nonviral gene therapy: promises andchallenges. <strong>Gene</strong> Ther 7, 31-34Lleres D, Dauty E, Behr JP, Mely Y, Duportail G (2001) DNAcondensation by an oxidizable cationic detergent.Interactions with lipid vesicles. Chem Phys Lipids 111, 59-71Martin F, Boulikas T (1998) The challenge of liposomes in genetherapy. <strong>Gene</strong> Ther Mol Biol 1, 173-214Mazzanti M, Bustamante JO, Oberleithner H (2001) Electricaldimension of the nuclear envelope. Physiol Rev 81, 1-19Meier O, Greber UF (2003) Adenovirus endocytosis. J <strong>Gene</strong>Med 5, 451-462Meister A, Anderson ME (1983) Glutathione. Annu RevBiochem 52, 711-760Miller AD (1998) Cationic liposomes for gene therapy. AngewChem Int Ed 37, 1769-1785Miller AD (2003) The problem with cationic liposome/micellebasednon-viral vector systems for gene therapy. Curr MedChem 10, 1195-1211Moazed D, Noller HF (1987) Interaction of antibiotics withfunctional sites in 16S ribosomal RNA. Nature 327, 389-394Monsigny M, Roche A-C, Midoux P, Mayer R (1994)Glycoconjugates as carriers for specific delivery oftherapeutic drugs and genes. Adv Drug Deliv Rev 14, 1-24287
- Page 7 and 8:
Instructions to authors:Gene Therap
- Page 9:
Please submit an electronic version
- Page 12:
103-111 ResearchArticle113-133 Revi
- Page 17 and 18:
Gene Therapy and Molecular Biology
- Page 19 and 20:
Gene Therapy and Molecular Biology
- Page 21 and 22:
Gene Therapy and Molecular Biology
- Page 23 and 24:
Gene Therapy and Molecular Biology
- Page 25 and 26:
Gene Therapy and Molecular Biology
- Page 27 and 28:
Gene Therapy and Molecular Biology
- Page 29 and 30:
Gene Therapy and Molecular Biology
- Page 31 and 32:
Gene Therapy and Molecular Biology
- Page 33 and 34:
Gene Therapy and Molecular Biology
- Page 35 and 36:
Gene Therapy and Molecular Biology
- Page 37 and 38:
Gene Therapy and Molecular Biology
- Page 39 and 40:
Gene Therapy and Molecular Biology
- Page 41 and 42:
Gene Therapy and Molecular Biology
- Page 43 and 44:
Gene Therapy and Molecular Biology
- Page 45 and 46:
Gene Therapy and Molecular Biology
- Page 47 and 48:
Gene Therapy and Molecular Biology
- Page 49 and 50:
Gene Therapy and Molecular Biology
- Page 51 and 52:
Gene Therapy and Molecular Biology
- Page 53 and 54:
Gene Therapy and Molecular Biology
- Page 55 and 56:
Gene Therapy and Molecular Biology
- Page 57 and 58:
Gene Therapy and Molecular Biology
- Page 59 and 60:
Gene Therapy and Molecular Biology
- Page 61 and 62:
Gene Therapy and Molecular Biology
- Page 63 and 64:
Gene Therapy and Molecular Biology
- Page 65 and 66:
Gene Therapy and Molecular Biology
- Page 67 and 68:
Gene Therapy and Molecular Biology
- Page 69 and 70:
Gene Therapy and Molecular Biology
- Page 71 and 72:
Gene Therapy and Molecular Biology
- Page 73 and 74:
Gene Therapy and Molecular Biology
- Page 75 and 76:
Gene Therapy and Molecular Biology
- Page 77:
Gene Therapy and Molecular Biology
- Page 80 and 81:
Epperly et al: Late injection of Mn
- Page 82 and 83:
Epperly et al: Late injection of Mn
- Page 84 and 85:
Goldberg-Cohen et al: Regulation of
- Page 86 and 87:
Goldberg-Cohen et al: Regulation of
- Page 88 and 89:
Goldberg-Cohen et al: Regulation of
- Page 90 and 91:
Gascón-Irún et al: Gene therapy a
- Page 92 and 93:
Gascón-Irún et al: Gene therapy a
- Page 94 and 95:
Gascón-Irún et al: Gene therapy a
- Page 96 and 97:
Gascón-Irún et al: Gene therapy a
- Page 98 and 99:
Gascón-Irún et al: Gene therapy a
- Page 100 and 101:
Gascón-Irún et al: Gene therapy a
- Page 102 and 103:
Gascón-Irún et al: Gene therapy a
- Page 104 and 105:
Gascón-Irún et al: Gene therapy a
- Page 106 and 107:
Suzuki et al: Regulation of the Sp/
- Page 108 and 109:
Suzuki et al: Regulation of the Sp/
- Page 110 and 111:
Suzuki et al: Regulation of the Sp/
- Page 112 and 113:
Suzuki et al: Regulation of the Sp/
- Page 114 and 115:
Li et al: MET amplification in live
- Page 116 and 117:
Li et al: MET amplification in live
- Page 118 and 119:
Chavakis et al: Leukocyte adhesion
- Page 120 and 121:
Chavakis et al: Leukocyte adhesion
- Page 122 and 123:
Chavakis et al: Leukocyte adhesion
- Page 124 and 125:
Chavakis et al: Leukocyte adhesion
- Page 126 and 127:
Chavakis et al: Leukocyte adhesion
- Page 128 and 129:
Sanlioglu et al: Adenovirus mediate
- Page 130 and 131:
Sanlioglu et al: Adenovirus mediate
- Page 132 and 133:
Sanlioglu et al: Adenovirus mediate
- Page 134 and 135:
Sanlioglu et al: Adenovirus mediate
- Page 136 and 137:
Sanlioglu et al: Adenovirus mediate
- Page 138 and 139:
Sanlioglu et al: Adenovirus mediate
- Page 140 and 141:
Sanlioglu et al: Adenovirus mediate
- Page 142 and 143:
Sanlioglu et al: Adenovirus mediate
- Page 144 and 145:
Sanlioglu et al: Adenovirus mediate
- Page 146 and 147:
Sanlioglu et al: Adenovirus mediate
- Page 148 and 149:
Sanlioglu et al: Adenovirus mediate
- Page 150 and 151:
George et al: Gene therapy for vasc
- Page 152 and 153:
George et al: Gene therapy for vasc
- Page 154 and 155:
George et al: Gene therapy for vasc
- Page 156 and 157:
George et al: Gene therapy for vasc
- Page 158 and 159:
George et al: Gene therapy for vasc
- Page 160 and 161:
George et al: Gene therapy for vasc
- Page 162 and 163:
George et al: Gene therapy for vasc
- Page 164 and 165:
George et al: Gene therapy for vasc
- Page 166 and 167:
George et al: Gene therapy for vasc
- Page 168 and 169:
Zhang et al: Angiogenic Gene Therap
- Page 170 and 171:
Zhang et al: Angiogenic Gene Therap
- Page 172 and 173:
Zhang et al: Angiogenic Gene Therap
- Page 174 and 175:
Zhang et al: Angiogenic Gene Therap
- Page 176 and 177:
Zhang et al: Angiogenic Gene Therap
- Page 178 and 179:
Zhang et al: Angiogenic Gene Therap
- Page 180 and 181:
Zhang et al: Angiogenic Gene Therap
- Page 182 and 183:
Xu et al: G-CSF receptor-mediated S
- Page 184 and 185:
Xu et al: G-CSF receptor-mediated S
- Page 186 and 187:
Xu et al: G-CSF receptor-mediated S
- Page 188 and 189:
Burek et al: Calcium induced cell d
- Page 190 and 191:
Burek et al: Calcium induced cell d
- Page 192 and 193:
Burek et al: Calcium induced cell d
- Page 194 and 195:
Burek et al: Calcium induced cell d
- Page 196 and 197:
David et al: Current status and fut
- Page 198 and 199:
David et al: Current status and fut
- Page 200 and 201:
David et al: Current status and fut
- Page 202 and 203:
David et al: Current status and fut
- Page 204 and 205:
David et al: Current status and fut
- Page 206 and 207:
David et al: Current status and fut
- Page 208 and 209:
David et al: Current status and fut
- Page 210 and 211:
David et al: Current status and fut
- Page 212 and 213:
David et al: Current status and fut
- Page 214 and 215:
David et al: Current status and fut
- Page 216 and 217:
David et al: Current status and fut
- Page 218 and 219:
David et al: Current status and fut
- Page 220 and 221:
David et al: Current status and fut
- Page 222 and 223:
David et al: Current status and fut
- Page 224 and 225:
David et al: Current status and fut
- Page 226 and 227:
Stoll et al: The role of EBV and ge
- Page 228 and 229:
Stoll et al: The role of EBV and ge
- Page 230 and 231:
Stoll et al: The role of EBV and ge
- Page 232 and 233:
Stoll et al: The role of EBV and ge
- Page 234 and 235:
Stoll et al: The role of EBV and ge
- Page 236 and 237:
Maruyama et al: Kidney-targeted pla
- Page 238 and 239:
Maruyama et al: Kidney-targeted pla
- Page 240 and 241:
Maruyama et al: Kidney-targeted pla
- Page 242 and 243:
Maruyama et al: Kidney-targeted pla
- Page 244 and 245:
Kren et al: Hepatocyte-targeted del
- Page 246 and 247:
Kren et al: Hepatocyte-targeted del
- Page 248 and 249:
Kren et al: Hepatocyte-targeted del
- Page 250 and 251: Kren et al: Hepatocyte-targeted del
- Page 252 and 253: Kren et al: Hepatocyte-targeted del
- Page 254 and 255: Zeng: PRL-3 as a target for cancer
- Page 256 and 257: Zeng: PRL-3 as a target for cancer
- Page 258 and 259: Zeng: PRL-3 as a target for cancer
- Page 260 and 261: Latchman: Protective effect of heat
- Page 262 and 263: Latchman: Protective effect of heat
- Page 264 and 265: Latchman: Protective effect of heat
- Page 266 and 267: Latchman: Protective effect of heat
- Page 268 and 269: Latchman: Protective effect of heat
- Page 270 and 271: Cai et al: Lung cancer gene therapy
- Page 272 and 273: Cai et al: Lung cancer gene therapy
- Page 274 and 275: Cai et al: Lung cancer gene therapy
- Page 276 and 277: Cai et al: Lung cancer gene therapy
- Page 278 and 279: Cai et al: Lung cancer gene therapy
- Page 280: Cai et al: Lung cancer gene therapy
- Page 283 and 284: Gene Therapy and Molecular Biology
- Page 285 and 286: Gene Therapy and Molecular Biology
- Page 287 and 288: Gene Therapy and Molecular Biology
- Page 289 and 290: Gene Therapy and Molecular Biology
- Page 291 and 292: Gene Therapy and Molecular Biology
- Page 293 and 294: Gene Therapy and Molecular Biology
- Page 295 and 296: Gene Therapy and Molecular Biology
- Page 297 and 298: Gene Therapy and Molecular Biology
- Page 299: Gene Therapy and Molecular Biology
- Page 303 and 304: Gene Therapy and Molecular Biology
- Page 305 and 306: Gene Therapy and Molecular Biology
- Page 307 and 308: Gene Therapy and Molecular Biology
- Page 309: Gene Therapy and Molecular Biology